ARGE Ankersmit Publications

Publications

  • Pulmonary metastasectomy
    Hoetzenecker K, Lang G, Ankersmit HJ, Klepetko W.
    European Surgery – Acta Chirurgica Austriaca 2011, Article in Press.
  • HSP27 and HSP70 serum and urine levels in patients suffering from chronic kidney disease
    Lebherz-Eichinger D, Ankersmit H.J, Hacker S, Hetz H, Kimberger O, Schmidt EM, Reiter T, Hörl WH, Haas M, Krenn CG, Roth GA. Clinica Chimica Acta, 2012 Jan 18;413(1-2):282-6. Epub 2011 Oct 18.
  • Reviewing ?-Gal in valve immunology
    Mangold A, Ankersmit HJ. European Journal of Cardio-Thoracic Surgery 2011 (publication status: accepted)
  • Apoptotische Leukozyten und deren Sekretionsprodukt. Relevanz für die Herzinfarkttherapie beim Menschen.
    Lichtenauer M, Mildner M, Gyöngyösi M, Ankersmit HJ. Wiener klinisches Magazin 5/2011.
  • Anti-alpha-Gal antibody titres remain unaffected by the consumption of fermented milk containing Lactobacillus casei in healthy adults.
    Mangold A, Hercher D, Hlavin G, Liepert J, Zimmermann M, Kollmann D, Feichtinger G, Lichtenauer M, Mitterbauer A, Ankersmit HJ. Int J Food Sci Nutr. 2011 Oct 4. [Epub ahead of print].
  • Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study.
    Lichtenauer M, Mildner M, Hoetzenecker K, Zimmermann M, Podesser BK, Sipos W, Berényi E, Dworschak D, Tschachler E, Gyöngyösi M, Ankersmit HJ. Basic Res Cardiol. 2011, 1-15, DOI 10.1007/s00395-011-0224-6.
  • Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction.
    Lichtenauer M, Mildner M, Baumgartner A, Hasun M, Werba G, Beer L, Altmann P, Roth G, Gyöngyösi M, Podesser BK, Ankersmit HJ. Basic Res Cardiol. 2011 Jun;106(4):645-55.
  • Increased total cytokeratin-18 serum and urine levels in chronic kidney disease.
    Roth GA, Lebherz-Eichinger D, Ankersmit HJ, Hacker S, Hetz H, Vukovich T, Perne A, Reiter T, Farr A, Hörl WH, Haas M, Krenn CG. Clin Chim Acta. 2011 Apr 11;412(9-10):713-7.
  • Effect of PBS Solutions on Chemokine Secretion of Human Peripheral Blood Mononuclear Cells.
    Lichtenauer M, Nickl S, Hoetzenecker K, Mangold A, Mitterbauer A, Hacker S, Zimmermann M, Ankersmit HJ. American Laboratory 2011;43(1):30-33.
  • Identification of oncostatin M as a STAT5-dependent mediator of bone marrow remodeling in KIT D816V-positive systemic mastocytosis.
    Hoermann G, Cerny-Reiterer S, Perné A, Klauser M, Hoetzenecker K, Klein K, Müllauer L, Gröger M, Nijman SM, Klepetko W, Valent P, Mayerhofer M. Am J Pathol. 2011 May;178(5):2344-56. Epub 2011 Mar 31.
  • Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure
    Roth GA, Zimmermann M, Lubsczy, BA, Pilz J, Faybik P, Hetz H, Hacker S, Mangold A, Bacher A, Krenn CG, Ankersmit HJ.
    Journal of Surgical Research, 163 (2) 2010, pp. e79-e83.
  • Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes.
    Starlinger P, Moll HP, Assinger A, Nemeth C, Hoetzenecker K, Gruenberger B, Gruenberger T, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C. J Thromb Haemost. 2010 Aug;8(8):1809-19. doi: 10.1111/j.1538-7836.2010.03908.x. Epub 2010 May 12.
  • Research Update: Myocardial lipofuscin-laden lysosomes contain the apoptosis marker caspase-cleaved cytokeratin-18.
    Lichtenauer M, Ankersmit HJ. Eur J Clin Invest. 2010;40(9):770-789.
  • Impaired recovery of cardiac output and mean arterial pressure after successful defibrillation in patients with low left ventricular ejection fraction.
    Skhirtladze K, Mora B, Moritz A, Birkenberg B, Ankersmit HJ, Dworschak. Resuscitation. 2010 Sep;81(9):1123-7.
  • Early immunomodulatory effects of linezolid in a human whole blood endotoxin model.
    Lambers C, Burian B, Binder P, Ankersmit HJ, Wagner C, Müller M, Zeitlinger M. Int J Clin Pharmacol Ther. 2010 Jul;48(7):419-24.
  • Considerations on infectious complications using a drowned lung for transplantation.
    Hoetzenecker K, Ankersmit HJ, Lang G, Scheed A, Marta G, Jaksch P, Klepetko W. Transpl Int. 2010 Jul;23(7):e32-4.
  • Spontaneous rupture of the inferior thyroid artery resulting in mediastinal hematoma.
    Hoetzenecker K, Töpker M, Klepetko W, Ankersmit HJ. Interact Cardiovasc Thorac Surg. 2010 Aug;11(2):209-10.
  • Apelin expression in human non-small cell lung cancer: Role in angiogenesis and prognosis.
    Berta J, Kenessey I, Dobos J, Tovari J, Klepetko W, Ankersmit HJ, Hegedus B, Renyi-Vamos F, Varga J, Lorincz Z, Paku S, Ostoros G, Rozsas A, Timar J, Dome B. J Thorac Oncol. 2010 Aug;5(8):1120-9.
  • Primary sources and immunological prerequisites for sST2 secretion in humans.
    Mildner M, Storka A, Lichtenauer M, Mlitz V, Ghannadan M, Hoetzenecker K, Nickl S, Dome B, Tschachler E, Ankersmit HJ. Cardiovasc Res. 2010 Sep 1;87(4):769-77.
  • Effect of PBS Solutions on Chemokine Secretion of Human Peripheral Blood Mononuclear Cells.
    Lichtenauer M, Nickl S, Hoetzenecker K, Mangold A, Mitterbauer A, Hacker S, Zimmermann M, Ankersmit HJ. American Laboratory 2011;43(1):30-33
  • Questionable model choice in valve calcification research addressing alpha-Gal.
    Mangold A, Ankersmit HJ. J Heart Lung Transplant. 2010 Aug;29(8):911-2; discussion 912-3. Epub 2010 Jun 8.
  • Reply to the Editor.
    Ankersmit HJ. Journal of Thoracic and Cardiovascular Surgery 139 (2) 2010, pp. 512.
  • Reply to the Editor
    Hoetzenecker K, Ankersmit HJ, Lang IM. Journal of Thoracic and Cardiovascular Surgery, 138 (3) 2009, p. 786.
  • Antivascular agents for non-small-cell lung cancer: current status and future directions.
    Amir E, Mandoky L, Blackhall F, Thatcher N, Klepetko W, Ankersmit HJ, Reza Hoda MA, Ostoros G, Dank M, Dome B. Expert Opin Investig Drugs. 2009 Nov;18(11):1667-86.
  • Increased Soluble Serum Markers Caspase-Cleaved Cytokeratin-18, Histones, and ST2 Indicate Apoptotic Turnover and Chronic Immune Response in COPD. Hacker S, Lambers C, Pollreisz A, Hoetzenecker K, M Lichtenauer, Mangold A, Niederpold T, Hacker A, Lang G, Dworschak M, Vukovich T, Gerner C, Klepetko W, Ankersmit HJ. J Clin Lab Anal. 2009;23(6):372-9.
  • Phosphate Buffered Saline Containing Calcium and Magnesium Elicits Increased Secretion of Interleukin-1 Receptor Antagonist.
    Lichtenauer M, Nickl S, Hoetzenecker K, Mangold A, Moser B, Zimmermann M, Hacker S, Niederpold T, Mitterbauer A, Ankersmit HJ. Laboratory Medicine, 40 (5) 2009, pp. 290-293.
  • Management of aortobronchial fistula developing 27 years after open aortic surgery by means of endovascular stent grafting.
    Hacker S, Langenberger H, Plank C, Gorlitzer M, Ehrlich M, Dolak W, Kreuzer S, MD, Loewe C, Klepetko W, Ankersmit HJ. Thorac Cardiovasc Surg 2010;139:778-780.
  • Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium.
    Ankersmit HJ, Hoetzenecker K, Dietl W, Soleiman A, Horvat R, Wolfsberger M, Gerner C, Hacker S, Mildner M, Moser B, Lichtenauer M, Podesser BK. Eur J Clin Invest. 2009 Jun;39(6):445-56.
  • Atrial septal defect repair after a 10-month treatment with bosentan in a patient with severe pulmonary arterial hypertension: a case report. Hoetzenecker K, Ankersmit HJ, Bonderman D, Hoetzenecker W, Seitelberger R, Klepetko W, Lang IM. J Thorac Cardiovasc Surg. 2009 Mar;137(3):760-1.
  • MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: A pilot study.
    Roth GA, Faybik P, Hetz H, Ankersmit HJ, Hoetzenecker K, Bacher A, Thalhammer T, Krenn CG. Scand J Gastroenterol. 2009 Feb 26:1-7.
  • High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
    Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Lang G, Hoda MA, Nierlich P, Dome B. Clin Cancer Res. 2009 Mar 1;15(5):1741-6.
  • Elevated HSP27, HSP70 and HSP90? in Chronic Obstructive Pulmonary Disease: Markers for Immune Activation and Tissue Destruction.
    Hacker S, Lambers S, Hoetzenecker K, Pollreisz A, Aigner C, Mangold A, Lichtenauer M, Taghavi S, Klepetko W, Ankersmit HJ. Clin Lab. 2009;55(1-2):31-40.
  • T-Cell Senescence And Contraction Of T-Cell Repertoire Diversity In Patients With Chronic Obstructive Pulmonary Disease.
    Lambers C, Hacker S, Posch M, Hoetzenecker K, Pollreisz A, Lichtenauer M, Klepetko W, Ankersmit HJ. Clin Exp Immunol. 2009 Mar;155(3):466-75.
  • Alpha-Gal Specific IgG Immune Response after Implantation of Bioprostheses. Mangold A, Hoetzenecker K, Hacker S, Lichtenauer M, Niederpold T, Dworschak, Szerafin T, Auer J, Blumer R, Ankersmit HJ. Thorac Cardiov Surg 2009; 57:191–195.
  • Secretion of Soluble ST2 – Possible Explanation for Systemic Immunosuppression after Heart Surgery
    Szerafin T, Niederpold T, Mangold A, Hoetzenecker K, Hacker S, Roth G, Lichtenauer M, Moser B, Dworschak M, Ankersmit HJ. Thorac Cardiovasc Surg. 2009; 57(1):25-9.
  • Cerebral desaturation during cardiac arrest: Its relation to arrest duration and left ventricular pump function.
    Skhirtladze K, Birkenberg B, Mora B, Moritz A, Ince I, Ankersmit HJ, Steinlechner B, Dworschak M. Critical Care Medicine, 37 (2) 2009, pp. 471-475.
  • Pro-inflammatory Interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment.
    Roth GA, Faybik P, Hetz H, Hacker S, Ankersmit HJ, Bacher A, Thalhammer T, Krenn CG. Digestive and Liver Disease, 41 (6) 2009, pp. 417-423.
  • Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
    Geusau A, Dunkler D, Messeritsch E, Sandor N, Heidler G, Rödler S, Ankersmit J, Zuckermann A, Tschachler E. Int J Dermatol. 2008 Sep;47(9):918-25.
  • Myocardial lipofuscin-laden lysosomes contain the apoptosis marker caspase-cleaved cytokeratin-18
    Soleiman A, Lukschal A, Hacker S, Aumayr K, Hoetzenecker K, Lichtenauer M, Moser B, Untersmayr E, Horvat R, Ankersmit HJ.
    European Journal of Clinical Investigation, 38 (10) 2008, pp. 708-712.
  • Basic and applied research at the department of cardio-thoracic surgery: Work in progress
    Ankersmit HJ, Podesser BK, Aharinejad S, Mohl W.
    Wiener Klinische Wochenschrift, 120 (SUPPL. 2)2008, pp. 39-45.
  • An Early Marker of Apoptosis, Caspase-cleaved Cytokeratin-18, is Deposited in Myocardial Lipofuscin.
    Soleiman A, Lukschal A, Hacker S, Aumayr K, Hoetzenecker K, Lichtenauer M, Untersmeier  E, Horvat R, Ankersmit HJ. European Journal of Clinical Investigation Vol 38, 2008, 708-12.
  • Consequences of a wait-and-see Strategy for Benign Metastasizing Leiomyomatosis of the Lung.
    Hoetzenecker K, Ankersmit HJ, Aigner C, Lichtenauer M, Kreuzer S, Hacker S, Hoetzenecker W, Lang G, Klepetko W. The Annals of Thoracic Surgery 2008.
  • Levels of sCD40, sCD40L, TNF? and TNF-RI in the Culprit Coronary Artery During Myocardial Infarction.
    Hoetzenecker K, Adlbrecht C, Hacker S, Hoetzenecker W, Lichtenauer M, Mangold A, Moser B, Lang G, Lang IM, Muehlbacher F, Klepetko W, Ankersmit HJ. LABMEDICINE, Volume 40, No. 11, Nov 2009, 660-664.
  • Atrial septal defect repair after a 10-month treatment with bosentan in a patient with severe pulmonary arterial hypertension: A case report Hoetzenecker K, Ankersmit HJ, Bonderman D, Hoetzenecker W, Seitelberger R, Klepetko W, J Thorac Cardiovasc Surg.2009; 137: 760-761.
  • Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro.
    Pollreisz A, Assinger A, Hacker S, Hoetzenecker K, Lang G, Wolfsberger M, Steinlechner B, Bielek E, Lalla E, Klepetko W, Volf I, Ankersmit HJ. Br J Dermatol. 2008 Jun 18.
  • Gigantic Coronary Fistula.
    Ankersmit HJ, Hacker S, Hoetzenecker K, Grimm M. Wien Klin Wochenschr. 2008;120(5-6):152.
  • Heat shock proteins 27, 60, 70, 90alpha, and 20S proteasome in on-pump versus off-pump coronary artery bypass graft patients.
    Szerafin T, Hoetzenecker K, Hacker S, Horvath A, Pollreisz A, Arpád P, Mangold A, Wliszczak T, Dworschak M, Seitelberger R, Wolner E, Ankersmit HJ. The Annals of Thoracic Surgery 2008 Jan;85(1):80-7.
  • Cytomegalovirus hyperimmunoglobulin: mechanisms in allo-immune response in vitro.
    Hoetzenecker K, Hacker S, Hoetzenecker W, Sadeghi K, Sachet M, Pollreisz A, Mangold A, Wliszczak T, Bielek E, Muehlbacher F, Klepetko W, Ankersmit HJ. European journal of clinical investigation 2007 Dec;37(12):978-86.
  • Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells.
    Roth GA, Moser B, Roth-Walter F, Giacona MB, Harja E, Papapanou PN, Schmidt AM, Lalla E.
    Atherosclerosis. 2007 Feb;190(2):271-81. Epub 2006 Apr 18.
  • Caspase-cleaved cytokeratin 18 and 20 S proteasome in liver degeneration. Hetz H, Hoetzenecker K, Hacker S, Faybik P, Pollreisz A, Moser B, Roth G, Hoetzenecker W, Lichtenauer M, Klinger M, Krenn CG, Ankersmit HJ. Journal of Clinical Laboratory Analysis 2007 Sep 10;21(5):277-281
  • Elevated levels of interleukin-1?-converting enzyme and caspase-cleaved cytokeratin-18 in acute myocardial infarction
    Adlbrecht C, Hoetzenecker K, Posch M, Steiner S, Kopp C, Hacker S, Auer J, Horvath R, Moser B, Roth G, Wolner E, Lang IM, Ankersmit HJ. European Journal of Clinical Investigation 2007 May;37(5):372-80.
  • Porphyromonas gingivalis infection and cell death in human aortic endothelial cells.
    Roth GA, Ankersmit HJ, Brown VB, Papapanou PN, Schmidt AM, Lalla E; FEMS Microbiology Letters 2007 Jul;272(1):106-13.
  • Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation.
    Moser B, Szabolcs MJ, Ankersmit HJ, Lu Y, Qu W, Weinberg A, Herold KC, Schmidt AM. American Journal of Transplantation 2007 Feb;7(2):293-302.
  • The impact of hypogammagammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation.
    Ankersmit HJ, Hacker S, Hoetzenecker K, Moser B, Wolner E; The Journal of Heart and Lung Transplantation 2006 Nov;25(11):1387-8.
  • Invited commentary.
    Ankersmit HJ, Moser B, Wolner E; The Annals of Thoracic Surgery 2006 Sep;82(3):893-4.
  • Neuronal injury after repeated brief cardiac arrests during internal cardioverter defibrillator implantation is associated with deterioration of cognitive function.
    Weigl M, Moritz A, Steinlechner B, Schmatzer I, Mora B, Fakin R, Zimpfer D, Ankersmit HJ, Khazen C, Dworschak M; Anesthesia and Analgesia 2006 Aug;103(2):403-9.
  • Apoptosis-specific activation markers in on- versus off-pump coronary artery bypass graft (CABG) patients.
    Szerafin T, Horvath A, Moser B, Hacker S, Hoetzenecker K, Steinlechner B, Brunner M, Roth G, Boltz-Nitulescu G, Peterffy A, Wolner E, Ankersmit HJ. Clinical Laboratory 2006;52(5-6):255-61.
  • Recovery from giant cell myocarditis with ECMO support and utilisation of polyclonal antithymocyte globulin: a case report.
    Ankersmit HJ, Ullrich R, Moser B, Hoetzenecker K, Hacker S, German P, Krenn C, Horvat R, Grimm M, Wolner E, Zuckermann A; The Thoracic and Cardiovascular Surgeon 2006 Jun;54(4):278-80.
  • Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients.
    Ploder M, Pelinka L, Schmuckenschlager C, Wessner B, Ankersmit HJ, Fuerst W, Redl H, Roth E, Spittler A; Shock 2006 Feb;25(2):129-34.
  • Soluble ST2 protein in cardiac surgery: a possible negative feedback loop to prevent uncontrolled inflammatory reactions.
    Szerafin T, Brunner M, Horváth A, Szentgyörgyi L, Moser B, Boltz-Nitulescu G, Péterffy A, Hoetzenecker K, Steinlechner B, Wolner E, Ankersmit HJ. Clinical Laboratory 2005;51(11-12):657-63.
  • Endothelin activation and postoperative renal failure after human liver transplantation.
    Hetz H, Bauer M, Lahner D, Faybik P, Winning J, Ankersmit HJ, Bacher A, Krenn CG; Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005 Oct;11(10):1201-6.
  • Heightened levels of circulating 20S proteasome in critically ill patients. Roth GA, Moser B, Krenn C, Roth-Walter F, Hetz H, Richter S, Brunner M, Jensen-Jarolim E, Wolner E, Hoetzenecker K, Boltz-Nitulescu G, Ankersmit HJ; European Journal of Clinical Investigation 2005 Jun;35(6):399-403. Abstract
  • Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation?
    Gorlitzer M, Ankersmit J, Fiegl N, Meinhart J, Lanzenberger M, Unal K, Dunkler D, Kilo J, Wolner E, Grimm M, Grabenwoeger M; Transplant International : Official Journal of the European Society for Organ Transplantation 2005 Apr;18(4):390-5.
  • Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients.
    Untersmayr E, Bakos N, Schöll I, Kundi M, Roth-Walter F, Szalai K, Riemer AB, Ankersmit HJ, Scheiner O, Boltz-Nitulescu G, Jensen-Jarolim E; The FASEB Journal : Official publication of the Federation of American Societies for Experimental Biology 2005 Apr;19(6):656-8.
  • Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery. Konakci KZ, Bohle B, Blumer R, Hoetzenecker W, Roth G, Moser B, Boltz-Nitulescu G, Gorlitzer M, Klepetko W, Wolner E, Ankersmit HJ; European Journal of Clinical Investigation 2005 Jan;35(1):17-23. Abstract
  • Size-reduced lung transplantation: an advanced operative strategy to alleviate donor organ shortage.
    Aigner C, Winkler G, Jaksch P, Ankersmit J, Marta G, Taghavi S, Wisser W, Klepetko W; Transplantation Proceedings 2004 Nov;36(9):2801-5.
  • Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Taghavi S, Zuckermann A, Ankersmit J, Wieselthaler G, Rajek A, Laufer G, Wolner E, Grimm M; The Annals of Thoracic Surgery 2004 Nov;78(5):1644-9. Abstract
  • Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Roth GA, Zuckermann A, Klepetko W, Wolner E, Ankersmit HJ, Moser B, Volf I; Transplantation 2004 Oct 27;78(8):1238-9.
  • CDT values are not influenced by epithelial cell apoptosis in chronic alcoholic patients-preliminary results.
    Ramskogler K, Brunner M, Hertling I, Dvorak A, Kapusta N, Krenn C, Moser B, Roth G, Lesch OM, Ankersmit HJ, Walter H; Alcoholism, clinical and experimental research 2004 Sep;28(9):1396-8.
  • Elevated serum levels of epithelial cell apoptosis-specific cytokeratin 18 neoepitope m30 in critically ill patients.
    Roth GA, Krenn C, Brunner M, Moser B, Ploder M, Spittler A, Pelinka L, Sautner T, Wolner E, Boltz-Nitulescu G, Ankersmit HJ; Shock 2004 Sep;22(3):218-20.
  • Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients.
    Bonaros NE, Kocher A, Dunkler D, Grimm M, Zuckermann A, Ankersmit J, Ehrlich M, Wolner E, Laufer G; Transplantation 2004 Mar 27;77(6):890-7.
  • Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma.
    Brunner M, Krenn C, Roth G, Moser B, Dworschak M, Jensen-Jarolim E, Spittler A, Sautner T, Bonaros N, Wolner E, Boltz-Nitulescu G, Ankersmit HJ; Intensive Care Medicine 2004 Jul;30(7):1468-73.
  • Increased serum concentrations of soluble CD95/Fas and caspase 1/ICE in patients with acute angina.
    Ankersmit HJ, Weber T, Auer J, Roth G, Brunner M, Kvas E, Moser B, Spreitzer S, Lassnig E, Maurer E, Hartl P, Wolner E, Boltz-Nitulescu G, Eber B; Heart 2004 Feb;90(2):151-4.
  • A retrospective analysis of extracorporel membrane oxygenation versus right ventricular assist device in acute great failure after heart transplantation.
    Taghavi S, Ankersmit J, Zuckermann A, Roth GA, Wieselthaler G, Rajek A, Wolner E, Grimm M; Transplantation Proceedings 2003 Nov;35(7):2805-7.
  • Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance.
    Roth G, Moser B, Krenn C, Brunner M, Haisjackl M, Almer G, Gerlitz S, Wolner E, Boltz-Nitulescu G, Ankersmit HJ; Biochemical and Biophysical Research Communications 2003 Sep 5;308(4):840-6.
  • Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis.
    Moser B, Roth G, Brunner M, Lilaj T, Deicher R, Wolner E, Kovarik J, Boltz-Nitulescu G, Vychytil A, Ankersmit HJ; Biochemical and Biophysical Research Communications 2003 Aug 29;308(3):581-5.
  • Long-term survival (>10 years) of patients >60 years with induction therapy after cardiac transplantation.
    Zuckermann A, Dunkler D, Deviatko E, Bodhjalian A, Czerny M, Ankersmit J, Wolner E, Grimm M; European Journal of Cardio-thoracic Surgery 2003 Aug;24(2):283-91.
  • Immunobiologic consequences of assist devices.
    Itescu S, Schuster M, Burke E, Ankersmit J, Kocher A, Deng M, John R, Lietz K; Cardiology Clinics 2003 Feb;21(1):119-33.
  • CD32-mediated platelet aggregation in vitro by anti-thymocyte globulin: implication of therapy-induced in vivo thrombocytopenia.
    Ankersmit HJ, Roth GA, Moser B, Zuckermann A, Brunner M, Rosin C, Buchta C, Bielek E, Schmid W, Jensen-Jarolim E, Wolner E, Boltz-Nitulescu G, Volf I; American Journal of Transplantation 2003 Jun;3(6):754-9.
  • Rapamycin as rescue therapy in a patient supported by biventricular assist device to heart transplantation with consecutive ongoing rejection. Ankersmit HJ, Roth G, Zuckermann A, Moser B, Obermaier R, Taghavi S, Brunner M, Wieselthaler G, Lanzenberger M, Ullrich R, Laufer G, Grimm M, Wolner E; American Journal of Transplantation 2003 Feb;3(2):231-4.
  • Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients.
    Lietz K, John R, Schuster M, Ankersmit J, Burke E, Suciu-Foca N, Edwards N, Mancini D, Itescu S; Transplantation Proceedings 2002 Aug;34(5):1828-9.
  • Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients. Ankersmit HJ, Moser B, Zuckermann A, Roth G, Taghavi S, Brunner M, Wolner E, Boltz-Nitulescu G; Clinical and Experimental Immunology 2002 Apr;128(1):175-80.
  • Transitory immunologic response after implantation of the DeBakey VAD continuous-axial-flow pump.
    Ankersmit HJ, Wieselthaler G, Moser B, Gerlitz S, Roth G, Boltz-Nitulescu G, Wolner E; The Journal of Thoracic and Cardiovascular Surgery 2002 Mar;123(3):557-61.
  • Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy.
    Ankersmit HJ, Moser B, Roedler S, Teufel I, Zuckermann A, Roth G, Lietz K, Back C, Gerlitz S, Wolner E, Boltz-Nitulescu G; Clinical and Experimental Immunology 2002 Jan;127(1):183-9.
  • B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression. Schuster M, Kocher A, John R, Hoffman M, Ankersmit J, Lietz K, Edwards N, Oz M, Itescu S; Human Immunology 2002 Mar;63(3):211-20.
  • Backtable ventricular and atrial septal defect repair of an Eisenmenger allograft with concomitant domino heart transplantation.
    Gorlitzer M, Ankersmit HJ, Wollenek G, Wisser W, Wieselthaler G, Haisjackl M, Horvat R, Gabriel H, Wolner E, Grimm M; The Journal of Thoracic and Cardiovascular Surgery 2002 Feb;123(2):374-6.
  • Extracorporeal membrane oxygenation for graft failure after heart transplantation: recent Vienna experience.
    Taghavi S, Ankersmit HJ, Wieselthaler G, Gorlitzer M, Rajek A, Wolner E, Grimm M; The Journal of Thoracic and Cardiovascular Surgery 2001 Oct;122(4):819-20.
  • Aberrant T-cell activation via CD95 and apoptosis in peripheral T lymphocytes in stable heart transplant recipients.
    Ankersmit HJ, Moser B, Hoffman M, Kocher AA, Schlechta B, Boltz-Nitulescu G, Wolner E; Transplantation Proceedings 2001 Aug;33(5):2860-1.
  • Outcome of pediatric heart transplantation: an analysis of 27 cases. Schlechta B, Kocher AA, Ehrlich M, Ankersmit J, Ploner M, Walch K, Nourani F, Czerny M, Wolner E, Wollenek G, Grimm M; Transplantation Proceedings 2001 Aug;33(5):2834-5.
  • Heart retransplantation: institutional results of a series of 31 cases. Schlechta B, Kocher AA, Ehrlich M, Ankersmit J, Ploner M, Walch K, Nourani F, Czerny M, Wolner E, Grimm M; Transplantation Proceedings Aug;33(5):2759-61.
  • Etiology of pulmonary nodules after heart transplantation.
    Kocher AA, Funovics M, Khazen C, Ploner M, Ehrlich M, Schlechta B, Nourani F, Ankersmit J, Wolner E, Laufer G; Transplantation Proceedings 2001 Aug;33(5):2757-8.
  • Effect of ABO blood type matching in cardiac transplant recipients.
    Kocher AA, Schlechta B, Ehrlich M, Ploner M, Khazen C, Schuster MP, Ankersmit J, Grimm M, Wolner E, Laufer G, Lassnigg A, Bonaros N; Transplantation Proceedings 2001 Aug;33(5):2752-4.
  • Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation.
    Lietz K, John R, Burke EA, Ankersmit JH, McCue JD, Naka Y, Oz MC, Mancini DM, Edwards NM; Transplantation 2001 Jul 27;72(2):277-83.
  • Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis. Ankersmit HJ, Deicher R, Moser B, Teufel I, Roth G, Gerlitz S, Itescu S, Wolner E, Boltz-Nitulescu G, Kovarik J; Clinical and Experimental Immunology 2001 Jul;125(1):142-8.
  • De novo inverted left atrial appendage: an unrecognized cause of left atrial mass with symptoms mimicking myxoma.
    Ankersmit HJ, Mohl W, Moser B, Kocher A, Ehrlich M, Grimm M, Horvat R, Wolner E; The Journal of Thoracic and Cardiovascular Surgery 2001 Jun;121(6):1211-3.
  • Automated implantable cardiac defibrillator and biventricular Thoratec assist device as bridge to transplantation in a patient with sarcoidosis. Ankersmit HJ, Wieselthaler GA, Moser B, Taghavi S, Grimm M, Roth G, Gorlitzer M, Tschernich H, Horvat R, Wolner E; The Journal of Thoracic and Cardiovascular Surgery 2001 Jun;121(6):1198-9.
  • Induction of CD40 ligand expression in human T cells by biomaterials derived from left ventricular assist device surface.
    Schuster M, Kocher A, Lietz K, Ankersmit J, John R, Edwards N, Oz M, Itescu S; Transplantation Proceedings 2001 Feb-Mar;33(1-2):1960-1.
  • Induction of T-cell apoptosis by polyurethane biomaterials used in left ventricular assist devices is dependent on calcineurin activation.
    Schuster M, Ankersmit J, Kocher A, Lietz K, Schuster N, Hofmann M, John R, Edwards N, Oz M, Itescu S; Transplantation Proceedings 2001 Feb-Mar;33(1-2):1958-9.
  • Increased death inducing receptors in vivo and activation-induced T-cell death by anti-thymocyte antibody treatment of stable cardiac transplant recipients.
    Ankersmit H, Moser B, Teufel I, Hericis R, Grimm M, Boltz-Nitulescu G, Wolner EP; The Journal of Heart and Lung Transplantation 2001 Feb;20(2):187.
  • Immunobiology of left ventricular assist devices.
    Itescu S, Ankersmit JH, Kocher AA, Schuster MD; Progress in Cardiovascular Diseases 2000 Jul-Aug;43(1):67-80.
  • Inverted left atrial appendage masquerading as myxoma.
    Ankersmit HJ, Kocher A, Frank H, Mohl W, Wolner E; Circulation 2000 Jan 25;101(3):E42-3.
  • Effect of obesity on outcome after cardiac transplantation.
    Kocher AA, Ankersmit J, Khazen C, Ofner P, Zuckermann A, Grimm M, Schlechta B, Ehrlich M, Wolner E, Laufer G; Transplantation Proceedings 1999 Dec;31(8):3187-9.
  • Modified technique of delivering solutions to rat coronary arteries in the transplant setting.
    Nourani F, Laufer G, Hollensteiner H, Bergmeister H, Buschle M, Khazen C, Ankersmit J, Traxler H, Wolner E, Losert U, Kocher AA; Transplantation Proceedings 1999 Dec;31(8):3255-6.
  • Repair of an aortic aneurysm at the time of heart transplantation: report of two cases and review of the literature.
    Kocher A, Ehrlich M, Khazen C, Ankersmit J, Nourani F, Itescu S, Edwards NM, Wolner E, Laufer G; Transplantation Proceedings 1999 Dec;31(8):3184-6.
  • Midterm results after combined heart and kidney transplantation.
    Kocher AA, Khazen C, Ankersmit J, Ofner P, Schlechta B, Ehrlich M, Wolner E, Laufer G; Transplantation Proceedings 1999 Dec;31(8):3181-3.
  • Impact of retrograde cerebral perfusion on aortic arch aneurysm repair. Ehrlich MP, Fang WC, Grabenwöger M, Kocher A, Ankersmit J, Laufer G, Grubhofer G, Havel M, Wolner E; The Journal of Thoracic and Cardiovascular Surgery 1999 Dec;118(6):1026-32.
  • Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients.
    John R, Lietz K, Burke E, Ankersmit J, Mancini D, Suciu-Foca N, Edwards N, Rose E, Oz M, Itescu S; Circulation 1999 Nov 9;100(19 Suppl):II229-35.
  • Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Ankersmit HJ, Edwards NM, Schuster M, John R, Kocher A, Rose EA, Oz M, Itescu S; Circulation 1999 Nov 9;100(19 Suppl):II211-5.
  • Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device.
    Ankersmit HJ, Tugulea S, Spanier T, Weinberg AD, Artrip JH, Burke EM, Flannery M, Mancini D, Rose EA, Edwards NM, Oz MC, Itescu S; Lancet 1999 Aug 14;354(9178):550-5.
  • Target cell susceptibility to lysis by human natural killer cells is augmented by alpha(1,3)-galactosyltransferase and reduced by alpha(1, 2)-fucosyltransferase.
    Artrip JH, Kwiatkowski P, Michler RE, Wang SF, Tugulea S, Ankersmit J, Chisholm L, McKenzie IF, Sandrin MS, Itescu S; The Journal of Biological Chemistry 1999 Apr 16;274(16):10717-22.
  • Combined heart and kidney transplantation using a single donor: a single center’s experience with nine cases.
    Kocher AA, Schlechta B, Kopp CW, Ehrlich M, Ankersmit J, Ofner P, Langer F, Berlakovich GA, Grimm M, Wolner E, Laufer G; Transplantation 1998 Dec 27;66(12):1760-3.
  • Importance of CD49d-VCAM interactions in human monocyte adhesion to porcine endothelium.
    Kwiatkowski P, Artrip JH, Ankersmit J, Schuster M, John R, Wang SF, Ma N, Michler RE, Itescu S; Xenotransplantation 1998 Feb;5(1):67-74.
  • Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period.
    Itescu S, Kwiatkowski P, Artrip JH, Wang SF, Ankersmit J, Minanov OP, Michler RE; Human immunology 1998 May;59(5):275-86.

Patents

  • I. CELLULAR COPD DIAGNOSIS
    (2010)  ANKERSMIT, Jan, Hendrik
    Method for diagnosing the risk of a human subject to develop chronic obstructive pulmonary disease (COPD) comprising the steps of: – providing a sample from a human subject, – determining the amount of CD4+CD28null T-cells in said sample, – diagnosing the …
    WO10000819
    Patent record available from the World Intellectual Property Organization (WIPO)
    v3.espacenet.com
  • II. COPD DIAGNOSIS
    (2010)  ANKERSMIT, Jan, Hendrik
    The present invention relates to a method for diagnosing chronic obstructive pulmonary disease (COPD) in a human subject or the risk of a human subject to develop COPD comprising the steps of : – providing a sample from a human subject, – determining the …
    WO10000820
    Patent record available from the World Intellectual Property Organization (WIPO)
    v3.espacenet.com
  • III. PHARMACEUTICAL PREPARATION COMPRISING SUPERNATANT OF BLOOD MONONUCLEAR CELL CULTURE
    (2010)  ANKERSMIT, Hendrik, Jan
    The present invention relates to a topical pharmaceutical preparation for treating an inflammatory skin condition, preferably a condition associated with ischemia, comprising a supernatant of a physiological solution obtainable by cultivating peripheral …
    WO10079086
    Patent record available from the World Intellectual Property Organization (WIPO)
    v3.espacenet.com
  • IV. PHARMACEUTICAL PREPARATION
    (2010)  ANKERSMIT, Hendrik Jan
    The present invention relates to a pharmaceutical preparation for treating an inflammatory condition, preferably a condition associated with ischemia comprising: a) a physiological solution comprising peripheral blood mononuclear cells (PBMCs) or a subset …
    WO10070105
    Patent record available from the World Intellectual Property Organization (WIPO)
    v3.espacenet.com
  • V. CELLULAR COPD DIAGNOSIS
    (2011)  ANKERSMIT, Jan, Hendrik
    Method for diagnosing the risk of a human subject to develop chronic obstructive pulmonary disease (COPD) comprising the steps of: – providing a sample from a human subject, – determining the amount of CD4+CD28nu11 T-cells in said sample, – diagnosing the …
    EP2307885
    Patent record available from the European Patent Office
    v3.espacenet.com
  • VI. METHOD FOR DIAGNOSING CARDIOVASCULAR DISEASES
    (2010)  ANKERSMIT, Hendrik, Jan
    Method for diagnosing a cardiovascular disease in an individual comprising the steps of: providing a sample of an individual; determining the amount of cytokeratin-18 (CK-18) or fragments thereof and/or interleukin-1beta precursor (IL-1beta precursor) in …
    EP2010921
    Patent record available from the European Patent Office
    v3.espacenet.com
  • VII. COPD diagnosis
    (2011)  Ankersmit, Jan Hendrik
    [0001]The present invention relates to a method for diagnosing chronic obstructive pulmonary disease (COPD) in a human subject comprising the steps of: – providing a sample from a human subject, – determining the amount of heat shock protein 27 (HSP27) in …
    EP2330424
    Patent record available from the European Patent Office
    v3.espacenet.com
  • VIII. PHARMACEUTICAL PREPARATION COMPRISING SUPERNATANT OF BLOOD MONONUCLEAR CELL CULTURE
    (2011)  ANKERSMIT, Hendrik, Jan
    The present invention relates to a topical pharmaceutical preparation for treating an inflammatory skin condition, preferably a condition associated with ischemia, comprising a supernatant of a physiological solution obtainable by cultivating peripheral …
    EP2379085
    Patent record available from the European Patent Office
    v3.espacenet.com
  • IX. COPD DIAGNOSIS
    (2011)  ANKERSMIT, Jan, Hendrik
    The present invention relates to a a method for diagnosing chronic obstructive pulmonary disease (COPD) in a human subject or the risk of a human subject to develop COPD comprising the steps of: – providing a sample from a human subject, – determining the …
    EP2307889
    Patent record available from the European Patent Office
    v3.espacenet.com
  • X. PHARMACEUTICAL PREPARATION
    (2011)  ANKERSMIT, Hendrik Jan
    The present invention relates to a pharmaceutical preparation for treating an inflammatory condition, preferably a condition associated with ischemia comprising a) a physiological solution comprising peripheral blood mononuclear cells (PBMCs) or a subset …
    EP2379086
    Patent record available from the European Patent Office
    v3.espacenet.com
  • XI. Cellular COPD diagnosis
    (2010)  Ankersmit, Jan Hendrik
    [0001]Method for diagnosing the risk of a human subject to develop chronic obstructive pulmonary disease (COPD) comprising the steps of: – providing a sample from a human subject, – determining the amount of CD4+CD28nu11 T-cells in said sample, – …
    EP2141498
    Patent record available from the European Patent Office
    v3.espacenet.com
  • XII. COPD diagnosis
    (2010)  Ankersmit, JanHendrik
    [0001]The present invention relates to a a method for diagnosing chronic obstructive pulmonary disease (COPD) in a human subject or the risk of a human subject to develop COPD comprising the steps of: – providing a sample from a human subject, – …
    EP2141499
    Patent record available from the European Patent Office
    v3.espacenet.com
  • XIII. Pharmaceutical preparation
    (2010)  Ankersmit, Hendrik Jan
    [0001]The present invention relates to a pharmaceutical preparation for treating an inflammatory condition, preferably a condition associated with ischemia comprising a) a physiological solution comprising peripheral blood mononuclear cells (PBMCs) or a …
    EP2201954
    Patent record available from the European Patent Office
    v3.espacenet.com
  • XIV. Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
    (2010)  Ankersmit, Hendrik Jan
    [0001]The present invention relates to a topical pharmaceutical preparation for treating an inflammatory skin condition, preferably a condition associated with ischemia, comprising a supernatant of a physiological solution obtainable by cultivating …
    EP2198873
    Patent record available from the European Patent Office
    v3.espacenet.com
  • XV. METHOD FOR DIAGNOSING CARDIOVASCULAR DISEASES
    (2007)  ANKERSMIT, Hendrik, Jan
    Method for diagnosing a cardiovascular disease in an individual comprising the steps of: providing a sample of an individual; determining the amount of cytokeratin-18 (CK-18) or fragments thereof and/or interleukin-1F precursor (IL-1F precursor) in said …
    WO07121495
    Patent record available from the World Intellectual Property Organization (WIPO)
    v3.espacenet.com
  • XVI. Method for Diagnosing Cardiovascular Diseases
    (2009)  Ankersmit, HendrikJan
    Method for diagnosing a cardiovascular disease in an individual comprising the steps of: providing a sample of an individual; determining the amount of cytokeratin-18 (CK-18) or fragments thereof and/or interleukin-1ß precursor (IL-1ß precursor) in said …
    US20090098104
    Patent record available from the US Patent Office
    appft1.uspto.gov/netacgi